Cytotoxic intracavitary chemotherapy.
Markman M.
Am J Med Sci. 1986 Mar;291(3):175-9. doi: 10.1097/00000441-198603000-00006.
Adalimumab-induced lupus serositis.
Kelly D, O'Connell O, Henry M.
BMJ Case Rep. 2015 Mar 4;2015:bcr2014207323. doi: 10.1136/bcr-2014-207323.
Clozapine-associated polyserositis.
Lim A, Sivakumaran P, Israel M.
N Z Med J. 2003 Oct 24;116(1184):U651.
Checkpoint-inhibitor induced Polyserositis with Edema.
Zierold S, Akcetin LS, Gresser E, Maier AM, König A, Kramer R, Theurich S, Tomsitz D, Erdmann M, French LE, Rudelius M, Heinzerling L.
Cancer Immunol Immunother. 2022 Dec;71(12):3087-3092. doi: 10.1007/s00262-022-03211-7. Epub 2022 May 16.
Carbimazole-induced lupus.
Haq I, Sosin MD, Wharton S, Gupta A.
BMJ Case Rep. 2013 Feb 6;2013:bcr2012007596. doi: 10.1136/bcr-2012-007596.
Sulfasalazine-induced lupus erythematosus.
Clementz GL, Dolin BJ.
Am J Med. 1988 Mar;84(3 Pt 1):535-8. doi: 10.1016/0002-9343(88)90279-3.
Pearls for the diagnosis and possible pathophysiological mechanisms of valproic acid-induced lupus erythematosus: A literature review.
Papadopoulou E, Saroglou M, Ismailos G, Fletsios D, Tsavlis D, Tryfon S.
Lupus. 2022 May;31(6):650-658. doi: 10.1177/09612033221088445. Epub 2022 Mar 24.
Tumor necrosis factor inhibitor-induced serositis.
Annapureddy N, Agarwal SK, Ammakkanavar N, Kanakadandi V, Sabharwal MS, Sanjani HP, Simoes P, Nadkarni GN.
Am J Ther. 2014 Sep-Oct;21(5):e166-8. doi: 10.1097/MJT.0b013e31826fc4d1.
Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors.
Kelly K, Swords R, Mahalingam D, Padmanabhan S, Giles FJ.
Target Oncol. 2009 Apr;4(2):99-105. doi: 10.1007/s11523-009-0110-4. Epub 2009 Apr 21.
Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature.
Shovman O, Tamar S, Amital H, Watad A, Shoenfeld Y.
Clin Rheumatol. 2018 Feb;37(2):563-568. doi: 10.1007/s10067-017-3884-2. Epub 2017 Oct 23.
